Cannabidiol
Check on psychonaut
CBD
Check on isomerdesign
(+)-CBD
Check on isomerdesign
epi-CBD
Check on isomerdesign
Cannabidiol
Check on drugmap
Cannabidiol
Check on wiki
Data
InChI: InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3
Synonyms: DB09061,(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol,CANNABIDIOL SOLUTION [USP-RS],CANNABIDIOL [ORANGE BOOK],Cannabidiol solution, ~10 mg/mL in ethanol, analytical standard, for drug analysis,(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol,1,3-benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, Epidiolex,(-)-Cannabidiol (CBD),Delta(1(2))-trans-cannabidiol,13956-29-1,CANNABIDIOL [INN],Cannabidiol solution,GWP-42003, (-)-Cannabidiol, 13956-29-1,2-[(1R,6R)-3-methyl-6-prop-1-en-2-yl-1-cyclohex-2-enyl]-5-pentylbenzene-1,3-diol,ZINC4097406,Cannabidiol [USAN],19GBJ60SN5,BDBM50121429,CARDIOLRX,2-((1R,6R)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-2-EN-1-YL)-5-PENTYLBENZENE-1,3-DIOL,CANNABIDIOL [INCI],2-((1R,6R)-6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol,delta1(2)-trans-Cannabidiol,2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol, delta1(2)-trans-Cannabidiol,Sativex (CBD + THC, fixed-dose oral spray),SCHEMBL119679,AC-34022,(-)-Cannabidiol (Synthetic),DB-093531,cannabidiolum,1,3-Benzenediol, 2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, (1R-trans)-,(-)-trans-Cannabidiol,UNII-19GBJ60SN5,Q422917,epi-CBD,D10915, (-)-trans-Cannabidiol,CHEMBL190461,(+)-CBD,HB2785,CHEBI:69478,CANNABIDIOL [MART.],2-(4-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol trans-,NCGC00386518-01,2-[3-Methyl-6-(methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol,Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, trans-(-)- (8CI),Cannabidiol (USAN/INN),C21H30O2,Cannabidiol (7CI),2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol,2-(6-Isopropenyl-3-methyl-2-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol #,2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol,(-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol, (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol,BDBM50318484,DTXSID301038839,nabiximols (CBD + THC, fixed-dose oral spray),P0T,(-)-Cannabidiol,AKOS032948358,Cannabidiol,CANNABIDIOL [USP-RS],cannabidiol,.delta.1(2)-trans-Cannabidiol,CANNABIDIOL [MI],Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, (+-)-,GTPL4150,BTX-1503,2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)CYCLOHEX-2-ENYL)-5-PENTYLBENZENE-1,3-DIOL,DTXSID00871959, UNII-19GBJ60SN5,ZYN002,Cannabidiol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,Cannabidiol solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis, GWP42003-P,2-(3-methyl-6-prop-1-en-2-yl-1-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol,C07578,2-(6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol (Cannabidiol), 19GBJ60SN5,(-)-Cannabidiol 1.0 mg/ml in Methanol,CANNABIDIOL [WHO-DD],(3R,4R)-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol,GWP-42003-P,GWP42003,(+/-)-Cannabidiol, CBD,(-)-CBD,(-)-Cannabidiol (CBD) 250 microg/mL in Acetonitrile,3556-78-3,BTX-1204,1,3-BENZENEDIOL, 2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL)-5-PENTYL-,CBD,GWP42003-P,Epidiolex, (-)-CBD,Epidiolex (TN),(-)-Cannabidiol (CBD) 1000 microg/mL in Methanol,Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, (-)-(E)-,(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydrobiphenyl-2,6-diol,1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-,D1(2)-trans-Cannabidiol,1,3-Benzenediol, 2-(4-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, trans-,2-(6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol,(-)-Cannabidiol (CBD) 100 microg/mL in Methanol, QHMBSVQNZZTUGM-ZWKOTPCHSA-N
Market name: cbd
Estimated data
Solubility: -5.755 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 83.5% (prediction based on www.mdpi.com)
